On Jul. 8, 2020, the National Institute of Allergy and Infectious Diseases announced it had established a new clinical trials network that aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19.